Brian A. Kane - 30 Nov 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Reporting relationship
EVP/President, Aetna
Issuer ticker
CVS
Reported as of
30 Nov 2023
Net transaction value
+$5,233,305
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Dec 2023, 17:54:03 UTC
Prior SEC filing
08 Sep 2023
Next SEC filing
03 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brian A. Kane

Key filing fact

Brian A. Kane filed Form 4 for CVS HEALTH Corp (CVS) on 01 Dec 2023.

Key facts

  • This page summarizes Brian A. Kane's Form 4 filing for CVS HEALTH Corp (CVS).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 01 Dec 2023, 17:54.

Change

  • Previous filing in this sequence was filed on 08 Sep 2023.
  • Current net transaction value: +$5,233,305.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
910
Date
30 Nov 2023
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVS transaction Derivative

Stock Option

Award

Transaction value
$5,233,305
Shares
+77,017
Change %
Price
$67.95
Shares after
77,017
Date
30 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
77,017
Exercise price
$67.95
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Option becomes exercisable in four equal annual installments, commencing 11/30/2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .